PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly EBITDA Margin came in at 28.98% in Q2 2026, down 96.0% year-over-year from 724.62% in Q2 2025, and up 26.1% quarter-over-quarter from 39.22% in Q1 2026.
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported EBITDA Margin for 7 consecutive years, with 28.98% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 96.0% year-over-year to 28.98% in Q2 2026; TTM through Jun 2026 was 33.86%, a 49.0% decrease from a year earlier, with the FY2025 full-year figure at 33.71%, up 932.0% from the prior year.
- EBITDA Margin was 28.98% for Q2 2026 at PROCEPT BioRobotics, up from 39.22% in the prior quarter.
- Over five years, EBITDA Margin peaked at 27.83% in Q3 2025 and troughed at 116.28% in Q1 2023.
- A 5-year average of 63.9% and a median of 56.18% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 6071 bps in 2022 and slumped 1175 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 105.31% in 2022, then jumped by 36 bps to 67.82% in 2023, then surged by 57 bps to 28.89% in 2024, then sank by 41 bps to 40.64% in 2025, then advanced by 29 bps to 28.98% in 2026.
- The last three EBITDA Margin figures came in at 28.98% (Q2 2026), 39.22% (Q1 2026), and 40.64% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 19.15% |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | -28.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.98% |
| Mar 31, 2026 | -39.22% |
| Dec 31, 2025 | -40.64% |
| Sep 30, 2025 | -27.83% |
| Jun 30, 2025 | -28.02% |
| Mar 31, 2025 | -39.67% |
| Dec 31, 2024 | -28.89% |
| Sep 30, 2024 | -38.42% |
| Jun 30, 2024 | -50.28% |
| Mar 31, 2024 | -62.08% |
| Dec 31, 2023 | -67.82% |
| Sep 30, 2023 | -72.96% |
| Jun 30, 2023 | -77.41% |
| Mar 31, 2023 | -116.28% |
| Dec 31, 2022 | -105.31% |
| Sep 30, 2022 | -108.63% |
| Jun 30, 2022 | -107.09% |
| Mar 31, 2022 | -110.61% |
| Dec 31, 2021 | -166.02% |
| Sep 30, 2021 | -147.63% |